Completion of treatment for latent TB infection in a low prevalence setting

Int J Tuberc Lung Dis. 2021 Apr 1;25(4):321-323. doi: 10.5588/ijtld.20.0862.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Latent Infection*
  • Latent Tuberculosis* / diagnosis
  • Latent Tuberculosis* / drug therapy
  • Latent Tuberculosis* / epidemiology
  • Prevalence
  • Risk Factors
  • Tuberculin Test